Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergo Vashakidze

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Thoracic Surgery Clinics|June 23, 2026
Surgery for Active and Drug-Resistant TuberculosisSergo Vashakidze, Mariana Buziashvili, Rosella Centis, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2017
Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans"Russell R Kempker, Charles A Peloquin, Henry M Blumberg, et al.
The Lancet. Infectious Diseases|January 28, 2012
Surgical treatment of drug-resistant tuberculosisRussell R Kempker, Sergo Vashakidze, Nelly Solomonia, et al.
International Journal of Mycobacteriology|January 4, 2017
Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis developmentNestani Tukvadze, Paula Cardona, Sergo Vashakidze, et al.
The Annals of Thoracic Surgery|May 7, 2013
Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgerySergo Vashakidze, Shota Gogishvili, Ketino Nikolaishvili, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2011
Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosisRussell R Kempker, Alexander S Rabin, Ketino Nikolaishvili, et al.
ERJ Open Research|September 9, 2020
Impact of adjuvant therapeutic surgery on the health-related quality of life of pulmonary tuberculosis patientsPau Benito, Sergo Vashakidze, Shota Gogishvili, et al.
Plos One|December 25, 2013
Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosisNino Lomtadze, Lali Kupreishvili, Archil Salakaia, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 24, 2016
Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in GeorgiaSergo Vashakidze, Albert Despuig, Shota Gogishvili, et al.
Bioinformatics (Oxford, England)|January 12, 2022
Benchmarking the empirical accuracy of short-read sequencing across the M. tuberculosis genomeMaximillian Marin, Roger Vargas, Michael Harris, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Thoracic Surgery Clinics|June 23, 2026
Surgery for Active and Drug-Resistant TuberculosisSergo Vashakidze, Mariana Buziashvili, Rosella Centis, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2017
Reply to Srivastava et al., "pH Conditions under Which Pyrazinamide Works in Humans"Russell R Kempker, Charles A Peloquin, Henry M Blumberg, et al.
The Lancet. Infectious Diseases|January 28, 2012
Surgical treatment of drug-resistant tuberculosisRussell R Kempker, Sergo Vashakidze, Nelly Solomonia, et al.
International Journal of Mycobacteriology|January 4, 2017
Development of the food supplement Nyaditum resae as a new tool to reduce the risk of tuberculosis developmentNestani Tukvadze, Paula Cardona, Sergo Vashakidze, et al.
The Annals of Thoracic Surgery|May 7, 2013
Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgerySergo Vashakidze, Shota Gogishvili, Ketino Nikolaishvili, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 27, 2011
Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosisRussell R Kempker, Alexander S Rabin, Ketino Nikolaishvili, et al.
ERJ Open Research|September 9, 2020
Impact of adjuvant therapeutic surgery on the health-related quality of life of pulmonary tuberculosis patientsPau Benito, Sergo Vashakidze, Shota Gogishvili, et al.
Plos One|December 25, 2013
Hepatitis C virus co-infection increases the risk of anti-tuberculosis drug-induced hepatotoxicity among patients with pulmonary tuberculosisNino Lomtadze, Lali Kupreishvili, Archil Salakaia, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 24, 2016
Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for Pulmonary Tuberculosis in GeorgiaSergo Vashakidze, Albert Despuig, Shota Gogishvili, et al.
Bioinformatics (Oxford, England)|January 12, 2022
Benchmarking the empirical accuracy of short-read sequencing across the M. tuberculosis genomeMaximillian Marin, Roger Vargas, Michael Harris, et al.
Pageof 3